Testing surgical AI across eight NHS hospitals: can workflow insights increase capacity?

The evaluation at a glance

Eight NHS hospitals are reported to be beginning a year-long evaluation of Proximie’s Intelligence Suite, according to Practice Business. The publication reports that the work will span 104 operating theatres, endoscopy suites and catheterisation laboratories, with more than 20,000 procedures expected to be covered. These figures describe the anticipated scope of the evaluation, rather than completed activity or evidence of improved performance.

Practice Business reports that a shared assessment framework will examine whether AI-generated insights into delays and the use of theatre time can improve efficiency and patient throughput. The reported aim is to explore increased capacity without adding theatres or staff. Whether that aim can be achieved is not yet clear: outcomes from the evaluation have not been reported.

From workflow insight to operational change

The question raised by the evaluation described by Practice Business is not simply whether AI can identify patterns in activity, but whether those insights can translate into measurable operational improvements. Identifying delays and increasing the number of patients treated are distinct propositions. The reported evaluation is intended to examine that relationship, rather than establish in advance that the technology will deliver additional capacity.

For the programme reported by Practice Business, it is not yet clear which types of delay will be assessed, how theatre time will be categorised, or how participating teams will use the resulting insights. Those unanswered questions leave the practical route from analysis to changed working patterns open. It is also not yet clear how any changes introduced during the year will be linked to the reported findings.

A shared framework across settings

According to Practice Business, the participating hospitals will use a shared assessment framework. That gives the reported evaluation a common approach to examining efficiency and throughput, although the detailed measures and methods are not yet clear. A shared framework should not, by itself, be read as evidence that results will be consistent across all participating settings.

The scope reported by Practice Business includes operating theatres, endoscopy suites and catheterisation laboratories. For surgeons interested in this evaluation, one question is whether any reported gains will appear across these settings or be concentrated in particular parts of the programme. It is not yet clear how results will be broken down by hospital, clinical setting or procedure type.

Understanding the eventual findings

Practice Business reports an expected total of more than 20,000 procedures over the year-long evaluation. That anticipated volume describes the scale of the work, but does not establish its eventual effect. It is not yet clear what comparison periods will be used, how starting performance will be recorded, or how changes unrelated to the AI-generated insights will be accounted for.

For the capacity question set out in Practice Business’s report, the distinction between better use of time and increased patient throughput will be important to understanding the eventual findings. At present, the reported programme offers an opportunity to examine those outcomes, not evidence that they have already been achieved. The central question remains open: can workflow insights support consistent improvements without additional theatres or staff?

This article is an overview for information only; readers should consult the original sources and appropriate professional guidance.